Open Access

The Abnormal Measures of Iron Homeostasis in Pediatric Obesity Are Associated with the Inflammation of Obesity

  • MatthewW Richardson1Email author,
  • Leybie Ang1, 2,
  • PaulF Visintainer3 and
  • ChrystalA Wittcopp4
International Journal of Pediatric Endocrinology20092009:713269

DOI: 10.1155/2009/713269

Received: 12 May 2009

Accepted: 31 July 2009

Published: 31 August 2009

Abstract

Objectives. To determine if the low iron state described in obese children is associated with the chronic inflammatory state seen in obesity. Study Design. Obese children age from 2 to 19 years seen at a weight management clinic were studied prospectively. Data were collected on age, gender, BMI, BMI -score, serum iron, ferritin, transferrin saturation, free erythrocyte protoporphyrin, high sensitivity creactive protein (hs-crp), and hemoglobin concentration. Results. 107 subjects were studied. Hs-crp levels correlated positively with BMI and BMI -score and negatively with serum iron . 11.2% of subjects had low serum iron. Median serum iron was significantly lower for subjects with American Heart Association high risk hs-crp values ( 3 mg/L) compared to those with low risk hs-crp ( 1 mg/L), (65 mcg/dL versus 96 mcg/dL, ). After adjusting for age, gender, and BMI -score, serum iron was still negatively associated with hs-crp . Conclusions. We conclude that the chronic inflammation of obesity results in the low iron state previously reported in obese children, similar to what is seen in other inflammatory diseases.

1. Introduction

Obesity is a substantial cause of morbidity among children. Diseases such as hypertension, hyperinsulinemia, depression, sleep apnea, and type 2 diabetes mellitus are all associated with pediatric obesity. It has been noted that obese children have a higher incidence of low serum iron than nonobese children [13]. Furthermore, data-based reviews have shown obese children to have additional measures of iron status such as ferritin, transferrin saturation, and free erythrocyte protoporphyrin that are consistent with iron deficiency at a high frequency [4, 5]. Obesity contributes to an inflammatory state, with elevated markers of inflammation such as high sensitivity c-reactive protein (hs-crp) [69]. Obese children have higher values of hs-crp than nonobese children, indicating that even very early obesity is associated with inflammation [10]. Chronic inflammation can lead to abnormal iron homeostasis by decreasing intestinal absorption of iron and promoting its sequestration into storage pools, such as macrophages of the reticuloendothelial system, thereby lowering circulating iron [11]. There thus exists a potential association between the inflammation of obesity and the low iron state of obesity. Such an association has been demonstrated in obese adults, but not children [12].

We sought to determine prospectively if the low iron state described with obesity is associated with the inflammation seen in obese children and to assess associations of inflammatory markers with other markers of iron status and Body Mass Index (BMI) in these children.

2. Patients and Methods

2.1. Patients

Over a 20-month period (10/15/2006 to 07/16/2008), children age from 2 to 19 years old seen at Baystate Children's Hospital Pediatric Weight Management Program with obesity (BMI greater than 95% for age) were screened with a questionnaire. Patients without an identified risk for iron deficiency or a red cell disorder (heavy menstrual periods, known bleeding from a gastrointestinal site, known elevated levels of lead, thalassemia, sickle cell disease, sideroblastic anemia, aplastic anemia, vegan diet) or a disorder associated with inflammation (inflammatory bowel disease, autoimmune disease, cancer treated within the last year) and those not taking iron supplements were eligible. Data on age, gender, BMI, and BMI -score were collected using the Pediatric Endocrinology Dynamic Record Organizer ((PEDRO), a commercial software program that utilizes the year 2000 growth charts). Subjects had blood samples drawn for complete blood count, serum iron, ferritin, transferrin saturation (serum iron/total iron binding capacity), free erythrocyte protoporphyrin (FEP), and hs-crp.

The study was approved by the Institutional Review Board of Baystate Medical Center. All subjects signed written informed consent or had parental consent with, if appropriate for developmental level, child assent.

2.2. Assessment of Iron Status, Anemia, and Inflammation

Iron status was assessed by serum iron (Roche Diagnostics Modular P analyzer), ferritin (Roche Diagnostics E170 analyzer), transferrin saturation (Roche Diagnostics Modular P analyzer), and FEP (Lab Corp of America). Low iron was defined as serum iron less than 45 mcg/dL. This value was chosen because it was below the lower 5th percentile for all age groups represented in the study and, for consistency across studies, it had been used previously [2, 13]. Iron deficiency was defined with the combination of ferritin, transferrin saturation, and FEP; if 2 of the 3 labs were abnormal for age, a subject was classified as iron deficient. These criteria have been used in the National Health and Nutrition Examination Survey (NHANES) III and in the previous studies on pediatric obesity and iron deficiency [4, 14] (Table 1a).

Table 1

(a) Cutoff values for laboratory tests of iron deficiency

Age

Serum

Transferrin

Free erythrocyte

(years)

Ferritin ( g/L)

saturation (%)

Protoporhytin ( g/dL RBC)

1-2

10

10

80

3–5

12

10

70

6–11

14

12

70

12–15

14

12

70

16

15

12

70

(b) Cutoff values for hemoglobin

Both sexes

  

Hemoglobin

Age (years)

  

(g/dL)

1-2

  

11.0

3–5

  

11.2

6–11

  

11.8

Female

   

12–15

  

11.9

16–19

  

12.0

Male

   

12–15

  

12.6

16–19

  

13.6

*Adapted with permission from Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997; 277 : 973–976.

Table 2

Demographic and laboratory profile of subjects.

107

Male

46 (43%)

Female

61 (57%)

Mean:

 

  Age (years)

  BMI (kg/m2)

  BMI z score

  Iron ( g/dL)

  Ferritin* (ng/mL)

  Transferrin (%)

  Saturation

 

  FEP+ ( g/dL RBC)

  Hemoglobin** (g/dL)

  Hs-crp (mg/L)

* ; + ; ** .

Table 3

Demographic and laboratory features of subjects with low iron status compared to subjects with normal iron status.

 

Low Iron ( 45 mcg/dL)

Normal Iron ( 45 mcg/dL)

(Wilcoxon Rank-Sum Test)

12

95

 

Male

5 (42%)

41 (43%)

 

Female

7 (58%)

54 (57%)

 

Mean

   

  Age (years)

.968

  BMI (kg/m2)

.141

  BMI -score

.102

  Hs-crp (mg/L)

.095

  Hemoglobin (gm/dL)

*

.005

  Ferritin ( g/L)

+

.003

  Transferrin saturation (%)

.001

  FEP ( g/dL RBC)

**

.001

* ; + ; ** .

Hemoglobin concentration was measured (Sysmex XE-2100) to assess for anemia, with cutoff values based on the 5th percentile for a reference group [14] (Table 1b).

High sensitivity crp (Roche Diagnostics Modular P analyzer) was used as a marker of inflammation. Hs-crp values were classified by American Heart Association (AHA) standards for risk for cardiovascular disease: Low ( 1 mg/L), Intermediate (1–3 mg/L), or High ( 3 mg/L).

2.3. Statistical Analysis

The distributions of all variables were examined. Those that were approximately normally distributed are reported with means and standard deviations. Nonnormally distributed variables are reported with medians and ranges. Since many variables did not meet assumptions of normality, nonparametric statistics were employed. Associations among variables which were at least ordinally scaled were estimated using the Spearman rank correlation. When comparing ordinal data across categorical variables, the Wilcoxon rank-sum test was used for categorical variables with two groups and the Kruskal-Wallis test was used for categorical variables with three or more groups. When a significant global test was achieved using the Kruskal-Wallis test, Bonferroni's adjustment for multiple comparisons was applied to the pairwise comparisons of groups. Unconditional logistic regression was used to determine the independent association between iron status and hs-crp, adjusting for potential confounders. All analyses were conducted using Stata (v.10.1, College Station, TX). Associations were considered significant at a critical level of 5%.

3. Results

3.1. Demographic and Clinical Characteristics (Table 2)

176 subjects were enrolled; 107 (60.8%) completed laboratory testing adequate to assess iron status and inflammation. There were no significant differences in mean age, mean BMI/BMI -score, or gender distribution for subjects who had laboratory studies drawn and those who did not.

3.2. Low Iron (Serum Iron 45 mcg/dL) (Table 3)

12 subjects (11.2%) were classified as having low iron. Mean hs-crp was higher in the low iron group than in the normal iron group, although this did not reach significance. Mean hemoglobin was significantly lower in the low iron group compared to the normal iron group. All additional measures of iron status were significantly different between the two groups, with ferritin and transferrin saturation lower and FEP higher in the low iron group than in the normal iron group. There were no significant differences in BMI, BMI -score, age, or gender between the two groups.

3.3. Iron Deficiency and Anemia

2 subjects (1.9%) met NHANES criteria for iron deficiency. Neither subject had anemia. 106 subjects had hemoglobin concentration measured. One subject (0.9%) had a hemoglobin concentration that was low for age and gender; all iron studies in this subject were above cutoff values.

3.4. Hs-crp (Figure 1)

87 (81%) of subjects had hs-crp levels classified as either AHA intermediate or high risk for cardiovascular disease. The group of subjects with high risk hs-crp had significantly lower median serum iron than those classified as low risk (65 mcg/dL, range 23–123 versus 96 mcg/dL, range 46–156, ). Mean BMI was higher in the high risk group compared to the low risk group (36.4 kg/m2   7.3 versus 32.1 kg/m2   6.2, ). There were no significant differences in age, gender, or BMI -score among the three risk groups.
Figure 1

Median serum iron by American Heart Association (AHA) risk for cardiovascular disease group.

3.5. Hs-crp Correlations (Spearman)

Hs-crp levels correlated positively with BMI ( , ), BMI -score ( , ), and ferritin ( , ) and negatively with serum iron ( , ), transferrin saturation ( , ), and hemoglobin ( , ).

3.6. Logistic Regression Analysis

After controlling for age, gender, and BMI -score, hypoferremia remained negatively associated with hs-crp ( ).

4. Discussion

This prospective study establishes the association between the inflammatory state, as identified by hs-crp, and the low iron state described in pediatric obesity. It also shows that the inflammation of obesity disturbs basic iron homeostasis as early as childhood and adolescence. Identification of the probable cause of the iron deficiency reported in obese children is especially important because this age group is particularly susceptible to the negative effects of iron deficiency, as discussed later.

Previous reports have proposed different mechanisms to explain the high rate of iron deficiency among obese children, including consumption of high calorie, iron-poor diets, sedentary lifestyle resulting in decreased myoglobin breakdown, and increased iron requirements for increased red cell mass. Our data support that it is the inflammation of obesity that negatively influences iron homeostasis. A similar association has been described in adults [12]. Anty et al. reported on obese adult women undergoing bariatric surgery who, when their BMI decreased postoperatively, showed a decrease in levels of crp with an associated improvement in markers of iron status, further suggesting that it is obesity that leads to inflammation which in turn contributes to abnormal measures of iron homeostasis [15].

It is known that obesity is associated with chronic low levels of inflammation [16]. Adipose tissue secretes a variety of proinflammatory cytokines including tumor necrosis factor alpha and interleukin-6 [16, 17]. The positive association of hs-crp with ferritin and negative associations with serum iron, transferrin saturation and hemoglobin, as shown in this study, are characteristic of inflammation's effects on measurements of iron homeostasis. A potential mechanism explaining the impact of obesity on iron status may involve the increased production of the protein hepcidin. Hepcidin is a key regulator of iron homeostasis, decreasing intestinal iron absorption and promoting iron sequestration in macrophages, effectively lowering serum iron and the bioavailability of iron. Hepcidin is produced primarily in the liver but is expressed in adipose tissue as well [18]. Its expression is increased by interleukin-6, which is higher in obese than nonobese children. In addition, there are data to suggest that hepcidin expression is increased by the adipose-derived hormone leptin [19].

In an attempt to isolate obesity's influence on iron status, subjects at risk for iron deficiency were excluded. Because of this, iron deficiency, as defined by NHANES criteria, in this screened population, was not as prevalent as in reviews of unscreened obese children [4]. When our rate of iron deficiency (1.9%) is added to the rate reported for nonobese children (2.1%), one gets a rate of iron deficiency closer to the 5.5% described for obese children [4]. Thus, the reported increase in iron deficiency among obese children may be attributable to the inflammation of obesity and its effects on measures of iron status.

Potential complications of iron deficiency during childhood and adolescence include poorer cognition, worse school achievement, and more behavior problems than in children without iron deficiency [2022]. Cournot et al. in a prospective study found an association between higher BMI and lower cognitive scores in middle aged men and women, but iron status was not assessed [23]. We are unaware of such descriptions in children but future research could investigate associations between BMI, iron status, and cognitive function.

In addition to its impact on iron homeostasis, inflammation is associated with the development of cardiovascular disease in adults. This study confirms elevated levels of hs-crp in obese children as well as the positive association between hs-crp and BMI/BMI -score [24, 25]. That is, the more obese a child is, the more systemic inflammation they are exposed to. The majority of the children in this study were significantly obese, with a mean BMI -score of 2.5 and had levels of hs-crp at intermediate or high risk for cardiovascular disease according to adult studies [26]. The full effects of years of such inflammation on children's cardiovascular health have yet to be determined. Baker et al. showed that an elevated BMI in childhood was associated with significantly increased risk of both fatal and nonfatal coronary heart disease later in life [27].

A potential limit of this study is that although at the time of enrollment subjects were screened for risks of inflammation, some subjects had blood drawn days or weeks later and could have been ill at the time of phlebotomy thus raising hs-crp levels above baseline. While possibly impacting lab variables such as hs-crp, ferritin, or iron, such a situation would not account for the positive association of hs-crp and BMI/BMI -score. Although we demonstrated correlations between BMI/BMI -score and hs-crp as well as between hs-crp and measurements of iron status, without nonobese subjects, it is difficult to assess the degree of effect weight status has on hs-crp and iron status.

These data raise several questions for future childhood obesity research. It has been demonstrated that weight loss is associated with reduction in crp [15, 28]. Does weight loss improve iron status in children as it has been suggested to do in some adults [15]? Is oral iron supplementation sufficient to correct low serum iron? Do anti-inflammatory medicines alter iron status in obese children? Does the low iron state of obesity contribute to poor neurocognitive function? Does the inflammation of obesity alter metabolism of other essential trace elements, such as zinc, copper, and selenium? Future research may address some of these questions.

This study provides the probable link between two long-known important aspects of pediatric obesity—chronic inflammation and abnormal, low iron status. It illustrates the pervasive nature that obesity has on children and their health, affecting even essential mineral metabolism, and shows that such effects start early in the disease, during childhood. Such data could ultimately be used to support evidence-driven public health policy and prevention of the disease.

Abbreviations

AHA: 

American Heart Association

FEP: 

Free erythrocyte protoporphyrin

Hs-crp: 

High sensitivity c-reactive protein

NHANES: 

National Health and Nutrition Examination Survey.

Authors’ Affiliations

(1)
Sections of Pediatric Hematology/Oncology, Baystate Children's Hospital
(2)
Department of Pediatric Emergency Medicine, Alberta Children's Hospital
(3)
Division of Academic Affairs, Baystate Health System
(4)
Sections of General Pediatrics and Pediatric Endocrinology, Baystate Children's Hospital

References

  1. Wenzel BJ, Stults HB, Mayer J: Hypoferremia in obese adolescents. The Lancet. 1962, 7251: 327-328. 10.1016/S0140-6736(62)90110-1.View ArticleGoogle Scholar
  2. Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M: Greater prevalence of iron deficiency in overweight and obese children and adolescents. International Journal of Obesity and Related Metabolic Disorders. 2003, 27 (3): 416-418. 10.1038/sj.ijo.0802224.View ArticlePubMedGoogle Scholar
  3. Selzer CC, Mayer J: Serum iron and iron binding capacity in adolescnts II. Comparison of obese and nonobese subjects. The American Journal of Clinical Nutrition. 1963, 13: 354-361.Google Scholar
  4. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. American Academy of Pediatrics. 2004, 114 (1): 104-108.Google Scholar
  5. Brotanek JM, Gosz J, Weitzman M, Flores G: Iron deficiency in early childhood in the United States: risk factors and racial/ethnic disparities. Pediatrics. 2007, 120 (3): 569-575. 10.1542/peds.2007-0572.View ArticleGoogle Scholar
  6. Weiss R, Dziura J, Burgert TS: Obesity and the metabolic syndrome in children and adolescents. The New England Journal of Medicine. 2004, 350 (23): 2362-2374. 10.1056/NEJMoa031049.View ArticlePubMedGoogle Scholar
  7. Hiura M, Kikuchi T, Nagasaki K, Uchiyama M: Elevation of serum C-reactive protein levels is associated with obesity in boys. Hypertension Research. 2003, 26 (7): 541-546. 10.1291/hypres.26.541.View ArticlePubMedGoogle Scholar
  8. Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Sancho J, San Millan JL: Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women. Diabetologia. 2003, 46 (5): 625-633.PubMedGoogle Scholar
  9. Ford ES, Ajani UA, Mokdad AH: The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005, 28 (4): 878-881. 10.2337/diacare.28.4.878.View ArticlePubMedGoogle Scholar
  10. Guran O, Akalin F, Ayabakan C, Dereli FY, Haklar G: High-sensitivity C-reactive protein in children at risk for coronary artery disease. Acta Paediatrica. 2007, 96 (8): 1214-1219. 10.1111/j.1651-2227.2007.00377.x.View ArticlePubMedGoogle Scholar
  11. Weiss G, Goodnough LT: Anemia of chronic disease. The New England Journal of Medicine. 2005, 352: 1011-1023. 10.1056/NEJMra041809.View ArticlePubMedGoogle Scholar
  12. Yanoff JB, Menzie CM, Denkinger B, McHugh T, Remaley AT, Yanovski JA: Inflammation and iron deficiency in the hypoferremia of obesity. International Journal of Obesity. 2007, 31 (9): 1412-1419. 10.1038/sj.ijo.0803625.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Nechyba C: Blood chemistries and body fluids in nechyba C and gunn VL eds. The Harriet Lane Handbook. Edited by: Nechyba C, Gunn VL. 2002, Mosby, Philadelphia, Pa, USA, 553-557. 16thGoogle Scholar
  14. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. The Journal of the American Medical Association. 1997, 277: 973-976. 10.1001/jama.277.12.973.View ArticlePubMedGoogle Scholar
  15. Anty R, Dahman M, Iannelli A: Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obesity Surgery. 2008, 18 (6): 709-714. 10.1007/s11695-007-9276-y.View ArticlePubMedGoogle Scholar
  16. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. The Journal of Clinical Investigation. 2005, 115: 1111-1119.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Sbarbati A, Osculati F, Silvagni D: Obesity and inflammation: evidence for an elementary lesion. Pediatrics. 2006, 117 (1): 220-223. 10.1542/peds.2004-2854.View ArticlePubMedGoogle Scholar
  18. Bekri S, Gual P, Anty R: Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006, 131: 788-796. 10.1053/j.gastro.2006.07.007.View ArticlePubMedGoogle Scholar
  19. Chung B, Matak P, McKie AT, Sharp P: Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. Journal of Nutrition. 2007, 137 (11): 2366-2370.PubMedGoogle Scholar
  20. Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG: Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics. 2001, 107 (6): 1381-1386. 10.1542/peds.107.6.1381.View ArticlePubMedGoogle Scholar
  21. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW: Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics. 2000, 105 (4): E51-10.1542/peds.105.4.e51.View ArticlePubMedGoogle Scholar
  22. Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J: Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. The Lancet. 1996, 348 (9033): 992-996. 10.1016/S0140-6736(96)02341-0.View ArticleGoogle Scholar
  23. Cournot M, Marquie JC, Ansiau D: Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology. 2006, 67 (7): 1208-1214. 10.1212/01.wnl.0000238082.13860.50.View ArticlePubMedGoogle Scholar
  24. Khaodhiar L, Ling P, Blackburn GL, Bistrian BR: Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. Journal of Parenteral and Enteral Nutrition. 2004, 28 (6): 410-415. 10.1177/0148607104028006410.View ArticlePubMedGoogle Scholar
  25. Diaz JJ, Arguelles J, Malaga I: C-reactive protein is elevated in the offspring of parents with essential hypertension. Archives of Disease in Childhood. 2007, 92 (4): 304-308. 10.1136/adc.2006.094672.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Yeh ET: High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clinical Cardiology. 2005, 28 (9): 408-412. 10.1002/clc.4960280905.View ArticlePubMedGoogle Scholar
  27. Baker JL, Olsen LW, Sorensen TIA: Childhood body-mass index and the risk of coronary heart disease in adulthood. The New England Journal of Medicine. 2007, 357 (23): 2329-2337. 10.1056/NEJMoa072515.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Shai I, Schwarzfuchs D, Henkin Y: Weight loss with a low-carbohydrate, mediterranean, or low-fat diet. The New England Journal of Medicine. 2008, 359: 229-241. 10.1056/NEJMoa0708681.View ArticlePubMedGoogle Scholar

Copyright

© Matthew W. Richardson et al. 2009

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement